share_log

開拓藥業-B：截至二零二四年二月二十九日止月份之股份發行人的證券變動月報表

KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

香港交易所 ·  Mar 4 16:31
Summary by Futu AI
開拓藥業-B（09939.HK）於2024年2月29日提交了最新的證券變動月報表。報告顯示，截至2024年2月底，公司的法定/註冊股本結存維持不變，為700,000,000股，每股面值0.0001美元，總額70,000美元。報告中未提及股份增減情況，並確認公司在當月發行的證券已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的所有要求。報告由開拓藥業的主席、執行董事及行政總裁童友之呈交。
開拓藥業-B（09939.HK）於2024年2月29日提交了最新的證券變動月報表。報告顯示，截至2024年2月底，公司的法定/註冊股本結存維持不變，為700,000,000股，每股面值0.0001美元，總額70,000美元。報告中未提及股份增減情況，並確認公司在當月發行的證券已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的所有要求。報告由開拓藥業的主席、執行董事及行政總裁童友之呈交。
PIONEERING PHARMACEUTICALS -B (09939.HK) FILED ITS LATEST SECURITIES MONTHLY CHANGE REPORT ON FEBRUARY 29, 2024. The report shows that as of the end of February 2024, the company's regulated/registered share capital was unchanged at 700,000,000 shares with a face value of $0.0001 per share for a total amount of $70,000. The report did not mention the increase in shares and confirmed that the securities issued by the company in the month were authorised by the Board and met all the requirements of the Listing Rules of the Stock Exchange of Hong Kong Limited. The report was presented by the Chairman, Executive Director, and Chief Executive Officer, Todou Yui.
PIONEERING PHARMACEUTICALS -B (09939.HK) FILED ITS LATEST SECURITIES MONTHLY CHANGE REPORT ON FEBRUARY 29, 2024. The report shows that as of the end of February 2024, the company's regulated/registered share capital was unchanged at 700,000,000 shares with a face value of $0.0001 per share for a total amount of $70,000. The report did not mention the increase in shares and confirmed that the securities issued by the company in the month were authorised by the Board and met all the requirements of the Listing Rules of the Stock Exchange of Hong Kong Limited. The report was presented by the Chairman, Executive Director, and Chief Executive Officer, Todou Yui.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.